PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Personalized Stem Cells, Inc, Poway, CA, USA. crogers@pscells.com.\', \'Personalized Stem Cells, Inc, Poway, CA, USA.\', \'Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA.\', \'Department of Surgery, Oregon Health and Science University, Portland, OR, USA.\', \'State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.\', \'Treatment and Research Center for Infectious Diseases, The Fifth Medical Center, Beijing, 100039, China.\', \'Calidi Biotherapeutics, Inc., San Diego, CA, USA.\', \'Department of Radiation Medicine and Applied Sciences, Moores UCSD Cancer Center, San Diego, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12967-020-02380-2
?:doi
?:hasPublicationType
?:journal
  • Journal of translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32423449
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.565
?:rankingScore_hIndex
  • 81
?:title
  • Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32423449>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32423449>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all